Entero Healthcare Solutions Ltd
NSE: ENTERO BSE: 544122
₹1581.10
-10.60 (0.67%)
Tue, 20 Oct 2026, 07:13 am
Market Cap (in Cr)6928.44
PE Ratio54.94
Dividend0
Distribution Services
Medical Distributors
24.5KEntero Healthcare Solutions Financials
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Total revenue | 17.80B | 25.22B | 33.00B | 39.22B | 50.96B |
| Gross profit | 447.59M | 697.81M | 1.10B | 1.69B | 2.48B |
| Operating expenses (excl. COGS) | -394.90M | -650.97M | -706.85M | -817.41M | -1.07B |
| Selling/general/admin expenses, total | -392.07M | -647.76M | -704.77M | -806.19M | -1.06B |
| Research & development | — | — | — | — | 0 |
| Selling/general/admin expenses, other | -392.07M | -647.76M | -704.77M | -806.19M | -1.06B |
| Other operating expenses, total | -2.83M | -3.21M | -2.08M | -11.22M | -6.12M |
| Operating income | 52.69M | 46.84M | 397.70M | 868.26M | 1.41B |
| Non-operating income, total | -161.07M | -244.95M | -434.58M | -512.71M | -26.83M |
| Interest expense, net of interest capitalized | -200.19M | -288.48M | -489.27M | -655.33M | -412.62M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 39.12M | 43.53M | 54.69M | 142.62M | 374.85M |
| Non-operating interest income | 29.43M | 34.39M | 40.90M | 133.32M | 368.68M |
| Miscellaneous non-operating expense | 9.69M | 9.14M | 13.79M | 9.30M | 6.17M |
| Unusual income/expense | 0 | 0 | 0 | 0 | 10.94M |
| Pretax income | -108.38M | -198.11M | -36.88M | 355.55M | 1.39B |
| Taxes | -45.16M | -96.28M | -74.16M | 42.44M | -313.05M |
| Non-controlling/minority interest | -1.83M | -4.81M | -4.53M | -6.90M | -126.14M |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | -155.37M | -299.20M | -115.57M | 391.09M | 948.20M |
| Net income | -155.37M | -299.20M | -115.57M | 391.09M | 948.20M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | — | — | — | 0 | 0 |
| Diluted net income available to common stockholders | -155.37M | -299.20M | -115.57M | 391.09M | 948.20M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - |
| EBITDA | 215.45M | 244.38M | 640.07M | 1.12B | 1.72B |
| EBIT | 52.69M | 46.84M | 397.70M | 868.26M | 1.41B |
| Total operating expenses | -17.74B | -25.17B | -32.60B | -38.35B | -49.54B |
| Prepaid expenses | 50.02M | 83.90M | 77.12M | 51.47M | 39.45M |
| Deferred income, current | 39.50M | 30.00K | 18.32M | 0 | — |
| Capital and operating lease obligations | 532.32M | 576.86M | 499.68M | 489.69M | 670.18M |
| Operating lease liabilities | — | — | — | — | — |
| Deferred tax liabilities | 22.70M | 29.92M | 31.06M | 193.55M | 0 |
| Deferred income, non-current | — | — | — | — | — |
| Minority interest | 16.94M | 21.75M | 26.34M | 33.28M | 462.11M |
| Change in accrued expenses | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | — | — | — | 0 | 0 |
